Free Trial

LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts

LeMaitre Vascular logo
$81.44 -0.86 (-1.04%)
As of 11:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LeMaitre Vascular Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 1After Market ClosesEstimated
Actual EPS
(Feb. 27)
$0.49
Consensus EPS
(Feb. 27)
$0.49

LeMaitre Vascular released Q4 2024 earnings on February 27, 2025, reporting an EPS of $0.49, which hit analysts' consensus estimates of $0.49. Quarterly revenue was reported to be $55.81 million, below analyst estimates of $55.99 million. With a trailing EPS of $1.94 and a P/E Ratio of 44.42, LeMaitre Vascular's earnings are expected to grow 11.86% next year, from $1.94 to $2.17 per share.

LMAT Upcoming Earnings

LeMaitre Vascular's next earnings date is estimated for Thursday, May 1, 2025, based off prior year's reporting schedules.

Get LeMaitre Vascular Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LeMaitre Vascular and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LMAT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LMAT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

LeMaitre Vascular Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$0.50$0.54$0.520.480 - 0.530
Q2 20252$0.51$0.53$0.52 
Q3 20252$0.51$0.57$0.54 
Q4 20252$0.53$0.60$0.57 
FY 20258$2.05$2.24$2.15 
Q1 20261$0.60$0.60$0.60 
Q2 20261$0.69$0.69$0.69 
Q3 20261$0.65$0.65$0.65 
Q4 20261$0.68$0.68$0.68 
FY 20264$2.62$2.62 $2.62
Remove Ads

LeMaitre Vascular Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/1/2025
(Estimated)
-------
2/27/2025Q4 2024$0.49$0.49-$0.49$55.99M$55.81M
10/31/2024Q3 2024$0.44$0.49+$0.05$0.49$53.50M$54.82M
8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98M$55.85M
5/2/2024Q1 2024$0.39$0.44+$0.05$0.44$51.50M$53.48M
2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01M$48.90M
11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58M$47.40M
8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29M$50.12M
5/2/2023Q1 2023$0.25$0.27+$0.02$0.27$43.54M$47.08M

LeMaitre Vascular Earnings - Frequently Asked Questions

LeMaitre Vascular has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on LMAT's earnings history.

LeMaitre Vascular updated its first quarter 2025 earnings guidance on Thursday, February, 27th. The company provided EPS guidance of 0.480-0.530 for the period, compared to the consensus estimate of 0.510. The company issued revenue guidance of $56.7 million-$58.7 million, compared to the consensus revenue estimate of $58.1 million.

In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.49 earnings per share (EPS) to hit the analysts' consensus estimate of $0.49. Learn more on analysts' earnings estimate vs. LMAT's actual earnings.

The conference call for LeMaitre Vascular's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for LeMaitre Vascular's latest earnings report can be read online.
Read Transcript

LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $219.86 million.

LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.94 earnings per share over the last four quarters.

LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 44.42 and a forward price-to-earnings ratio of 41.90. The price/earnings-to-growth ratio is 2.22.

LeMaitre Vascular's earnings are expected to grow from $1.94 per share to $2.17 per share in the next year, which is a 11.86% increase.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:LMAT) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners